Sign In
Buy GWPH
$218.96
+0 (+0%)
At Close: May 27, 2022
China poised to power huge growth in global offshore wind energy
05:01am, Wednesday, 05'th Aug 2020
Report finds the offshore industry could create 900,000 jobs globally over next decade
BP slashes dividend as Covid pushes it to record $16.8bn loss
06:44am, Tuesday, 04'th Aug 2020
Company to shift towards clean energy after writing down value of its oil and gas assets
France Solar Power Market Outlook 2020-2025 and Impact of COVID-19 - ResearchAndMarkets.com
12:00am, Tuesday, 04'th Aug 2020
The
Aug 03, 2020 (Stock Market Press via COMTEX) --
Sun Kissed Industries, Inc.'s (OTC: SKDI) Numuni Inc. subsidiary, a media monetization platform, today...
Aug 03, 2020 (Stock Market Press via COMTEX) --
Sun Kissed Industries, Inc.'s (OTC: SKDI) Numuni Inc. subsidiary, announces today (July 29, 2020), a...
FDA approves GW Pharmaceuticals' Epidiolex for new indication
08:11pm, Monday, 03'rd Aug 2020
CBD drug Epidiolex received approval from the U.S. Food and Drug Administration to treat seizures associated with a third medical condition, expanding the range of indications for the cannabis-derived
Why GW Pharmaceuticals Stock Is Up Today
07:45pm, Monday, 03'rd Aug 2020
Shares of GW Pharmaceuticals (NASDAQ: GWPH) are up by 4.8% as of 3:18 p.m. EDT on Monday, after rising by as much as 5.5% earlier in the day. The catalyst for these nice gains is the fact that the U.
GW Pharmaceuticals' Epidiolex Wins New FDA Approvals | The Motley Fool
07:36pm, Monday, 03'rd Aug 2020
The company's star CBD drug can now be prescribed for a new condition, and its age range for a previous approval has been expanded.
GW Pharma's stock rallies after its cannabinoid drug gets a new FDA approval
06:05pm, Monday, 03'rd Aug 2020
Shares of GW Pharmaceuticals undefined rallied 5.0% in trading on Monday after the drugmaker said its cannabinoid drug Epidiolex had received approval from...
GW Pharma's stock rallies after its cannabinoid drug gets a new FDA approval
06:05pm, Monday, 03'rd Aug 2020
Shares of GW Pharmaceuticals rallied 5.0% in trading on Monday after the drugmaker said its cannabinoid drug Epidiolex had received approval from the Food and Drug Administration for a new indication
Did Hedge Funds Make The Right Call On GW Pharmaceuticals plc (GWPH) ?
05:01pm, Monday, 03'rd Aug 2020
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and succes
Fluidigm COVID-19 Funding, And Other News: The Good, Bad And Ugly Of Biopharma (NASDAQ:FLDM)
12:03pm, Monday, 03'rd Aug 2020
Fluidigm receives NIH funding for COVID-19 testing technology. Stereotaxis receives positive fillip from first integrated cardiac ablation procedure.
FDA Approves EPIDIOLEX® (cannabidiol) Oral Solution to Treat Seizures Associated with Tuberous Sclerosis Complex
11:00am, Monday, 03'rd Aug 2020
– Age-range for all EPIDIOLEX indications expanded to include patients one year of age and older –– Third indication approved for EPIDIOLEX, the only FDA-approved Cannabidiol (CBD) medicine –
GW Pharma Scores New FDA Approval For CBD Drug Epidiolex
05:29am, Monday, 03'rd Aug 2020
Cannabis stock GW Pharma (GWPH) has announced that the US Food and Drug Administration (FDA) has approved Epidiolex oral solution for the treatment of seizures associated with tuberous sclerosis compl
